Treatment with 20(S)-ginsenoside Rg3 reverses multidrug resistance in A549/DDP xenograft tumors-Reference-Cited by-同舟云学术

Treatment with 20(S)-ginsenoside Rg3 reverses multidrug resistance in A549/DDP xenograft tumors

Published:2018-01-24 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Liu Chao¹,Gong Quan²,Chen Ting¹,Lv Juan¹,Feng Zhiping¹,Liu Pengjie¹,Deng Zhiyong¹

Affiliation:

1. Department of Nuclear Medicine, Yunnan Provincial Tumor Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650118, P.R. China

2. Department of Palliative Medicine, Yunnan Provincial Tumor Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650118, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Pivotal Hallmarks of Cancer for Enhanced Therapeutic Strategies in Triple-Negative Breast Cancer Treatment—In Vitro, In Vivo and Clinical Trials Literature Review;Cancers;2024-04-12

2. Ginsenoside Rg3: A Review of its Anticancer Mechanisms and Potential Therapeutic Applications;Current Topics in Medicinal Chemistry;2024-04

3. Panax notoginseng saponins reverse steroid resistance in lupus nephritis: Involvement of the suppression of exosomal P-gp levels from lymphocytes to glomerular endothelial cells;Biochemistry and Biophysics Reports;2023-12

4. Mechanism of multidrug resistance to chemotherapy mediated by P‑glycoprotein (Review);International Journal of Oncology;2023-08-28

5. Recent advances in ginsenosides against respiratory diseases: Therapeutic targets and potential mechanisms;Biomedicine & Pharmacotherapy;2023-02